Talk:Discovery and development of angiotensin receptor blockers
Latest comment: 15 years ago by PFHLai in topic Merge?
| This is the talk page for discussing improvements to the Discovery and development of angiotensin receptor blockers article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
 | A fact from Discovery and development of angiotensin receptor blockers appeared on Wikipedia's Main Page in the Did you know column on 22 November 2008 (check views). The text of the entry was as follows:
|  |
Merge?
editA merge with the Angiotensin II receptor antagonist article may be a good idea. We don't need two separate articles. --PFHLai (talk) 15:39, 17 November 2008 (UTC)
- This article was written as a part of a school project and we weren't allowed to base it on a page that already excisted. I actually think this one is much better than the Angiotensin II receptor antagonist article. But merge is not a bad idea.--Elinborgus
- Yes, it's much, much better. :-) Please see WT:PHARM#University project?. --PFHLai (talk) 13:24, 18 November 2008 (UTC)
In my opinion it is not critical to merge. It is a very interestring story.
By the way, there is a small mistake on the structure of eprosartan. There is no peroxyde group on that molecule. --Chemistlanglois 3:35, 20 november 2011